| Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses I Kleiter, A Gahlen, N Borisow, K Fischer, KD Wernecke, B Wegner, ... Annals of neurology 79 (2), 206-216, 2016 | 399 | 2016 |
| The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model C Geis, C Ritter, C Ruschil, A Weishaupt, B Grünewald, G Stoll, T Holmoy, ... Experimental Neurology 265, 8-21, 2015 | 65 | 2015 |
| Validating Alzheimer's disease micro RNAs using next-generation sequencing A Keller, C Backes, J Haas, P Leidinger, W Maetzler, C Deuschle, D Berg, ... Alzheimer's & Dementia 12 (5), 565-576, 2016 | 62 | 2016 |
| Specific induction of double negative B cells during protective and pathogenic immune responses C Ruschil, G Gabernet, G Lepennetier, S Heumos, M Kaminski, Z Hracsko, ... Frontiers in immunology 11, 606338, 2020 | 55 | 2020 |
| Differentiation between Guillain–Barré syndrome and acute-onset chronic inflammatory demyelinating polyradiculoneuritis—a prospective follow-up study using ultrasound and … A Grimm, H Oertl, E Auffenberg, V Schubert, C Ruschil, H Axer, N Winter Neurotherapeutics 16 (3), 838-847, 2019 | 43 | 2019 |
| Differential effects of disease modifying drugs on peripheral blood B cell subsets: a cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer … CL Kemmerer, V Pernpeintner, C Ruschil, A Abdelhak, M Scholl, ... PLoS One 15 (7), e0235449, 2020 | 25 | 2020 |
| Cladribine treatment specifically affects peripheral blood memory B cell clones and clonal expansion in multiple sclerosis patients C Ruschil, G Gabernet, CL Kemmerer, MA Jarboui, F Klose, S Poli, ... Frontiers in Immunology 14, 1133967, 2023 | 12 | 2023 |
| Low frequencies of central memory CD4 T cells in progressive multifocal leukoencephalopathy E Dubois, C Ruschil, F Bischof Neuroimmunology & Neuroinflammation 2 (6), e177, 2015 | 11 | 2015 |
| Treatment of progressive multiple sclerosis with high-dose all-trans retinoic acid – no clear evidence of positive disease modifying effects C Ruschil, E Dubois, MI Stefanou, MC Kowarik, U Ziemann, ... Neurological Research and Practice 3, 1-10, 2021 | 5 | 2021 |
| Next Generation Sequencing of Cerebrospinal Fluid B Cell Repertoires in Multiple Sclerosis and Other Neuro-Inflammatory Diseases—A Comprehensive Review C Ruschil, CL Kemmerer, L Beller, G Gabernet, MC Kowarik Diagnostics 11 (10), 1871, 2021 | 5 | 2021 |
| No evidence of oligoclonal bands, intrathecal immunoglobulin synthesis and B cell recruitment in acute ischemic stroke K Laichinger, P Bombach, J Dünschede, C Ruschil, MI Stefanou, ... PLoS One 18 (3), e0283476, 2023 | 3 | 2023 |
| Median nerve dissection after brachial artery catheterization revealed by high-resolution ultrasound MI Stefanou, V Schubert, C Ruschil, N Winter, MU Schuhmann, ... Clinical neurophysiology: official journal of the International Federation …, 2019 | 2 | 2019 |
| Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early … A Bayas, U Mansmann, BI Ön, VS Hoffmann, A Berthele, M Mühlau, ... Neurological Research and Practice 6 (1), 15, 2024 | 1 | 2024 |
| Clinical-Radiological Mismatch in Multiple Sclerosis Patients during Acute Relapse: Discrepancy between Clinical Symptoms and Active, Topographically Fitting MRI Lesions J Dünschede, C Ruschil, B Bender, A Mengel, T Lindig, U Ziemann, ... Journal of Clinical Medicine 12 (3), 739, 2023 | 1 | 2023 |
| Serum neurofilament light chain and glial fibrillary acidic protein as biomarkers in primary progressive multiple sclerosis and hereditary spastic paraplegia type 4 C Kessler, C Ruschil, A Abdelhak, C Wilke, A Maleska, J Kuhle, ... International Journal of Molecular Sciences 23 (21), 13466, 2022 | 1 | 2022 |
| Peripheral memory B cells in multiple sclerosis vs. double negative B cells in neuromyelitis optica spectrum disorder: disease driving B cell subsets during CNS inflammation MP Tieck, N Vasilenko, C Ruschil, MC Kowarik Frontiers in Cellular Neuroscience 18, 1337339, 2024 | | 2024 |
| Differential effects of ozanimod on B Cell repertoires in multiple sclerosis patients compared to other oral therapies N Vasilenko, C Ruschil, J Stadelamaier, A Maier, C Arnold, U Ziemann, ... MULTIPLE SCLEROSIS JOURNAL 29, 937-938, 2023 | | 2023 |
| Cladribine treatment exerts specific effects on memory B cell immunoglobulin repertoires in multiple sclerosis patients C Ruschil, G Gabernet, CL Kemmerer, U Ziemann, S Nahnsen, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 880-881, 2022 | | 2022 |
| Comparative multi-OMICS single cell atlas of five COVID-19 (rAdVV and mRNA) vaccines describe unique and distinct mechanisms of action Y Singh, AS Selting, G Gabernet, U Ray, R Bajaj, M Ali, M Loitz, ... bioRxiv, 2022.09. 12.507666, 2022 | | 2022 |
| Topographic mismatch between clinical relapse and MRI lesion mapping in multiple sclerosis patients J Dunschede, C Ruschil, C Kemmerer, E Burkle, B Bender, U Ziemann, ... | | 2021 |
